Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Drug and device firm doctor payments reach $6.5bn for 2014

1,444 companies made payments to around 600,000 physicians and 1,100 hospitals

- PMLiVE

Former Langland exec joins DJM Unlimited

Michael Le Brocq becomes the firm’s new director

Novartis day

Novartis heart drug may see novel pricing plan

Swiss firm looking to risk share with payers based on clinical outcomes

- PMLiVE

Roche and Evotec’s Alzheimer’s drug ineffective

Sembragiline failed to show cognitive and memory benefits

Pharma deals in June 2015

Allergan's $2.1bn acquisition of Kythera tops this month's deals

Great divides

The choices innovative companies make will lead to a fragmentary industry

- PMLiVE

Engaging patients in clinical trials

Multilingual, multimedia content is essentials of successful clinical trial communication

Celgene building

Celgene and Juno announce ten-year cancer deal

The firms’ pact will focus on the new area of immunotherapy

- PMLiVE

Novartis launches Apple Watch app for the visually impaired

Upgraded ViaOpta app already works on iPhone and Android phones

- PMLiVE

Opdivo approved via UK’s early drug access scheme

Bristol-Myers Squibb’s immunotherapy the first lung cancer drug approved by EAMS

- PMLiVE

Merck plans expanded filing for Emend this year

Nausea and vomiting therapy more effective than placebo in 1000-patient trial

Roche Basel Switzerland

Roche planning ocrelizumab filings in early 2016

Firm claims MS candidate outperformed Merck Serono’s Rebif in two phase III trials

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links